Sort by:

select Language:



EU Drug Markets Report

Eds.: European Monitoring Centre for Drugs and Drug Addiction, (2016)


Strategic Overview
https://publications.europa.eu/en/publication-deta...


Country overview: Uzbekistan

Eds.: European Monitoring Centre for Drugs and Drug Addiction, (2015)



http://www.emcdda.europa.eu/publications/country-o...


Country overview: Tajikistan

Eds.: European Monitoring Centre for Drugs and Drug Addiction, (2015)



http://www.emcdda.europa.eu/publications/country-o...


Role of sterile injection equipment and outreach programmes for injecting drug users

Eds.: World Health Organization, (2012)


Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related harm? Is advice on ways to reduce drug related harm safe and effective, using an outreach model of service delivery?
http://origin.who.int/mental_health/mhgap/evidence...


Treatment of psychostimulant dependence

Eds.: World Health Organization, (2012)


Q3: Are pharmacotherapies safe and effective for the treatment of psychostimulant dependence (maintenance or relapse prevention) in non-specialized settings?
http://origin.who.int/mental_health/mhgap/evidence...


EMCDDA Monographs

T. Rhodes; D. Hedrich, Eds.: European Monitoring Centre for Drugs and Drug Addiction, (2010)


Harm reduction: evidence, impacts and challenges -10-
https://files.zotero.net/7055221007/Rhodes%20und%2...


Module: Disorders due to substance abuse mhGAP

World Health Organization WHO, (2019)


Accessed: 21.03.2019 mhGAP Training Manual for the mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings – version 2.0 (for field testing)
www.who.int/mental_health/mhgap/sub_module.pdf?ua=...


88 hits